Literature DB >> 8280503

Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach.

L David, U Mandel, H Clausen, M Sobrinho-Simões.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280503     DOI: 10.1016/0959-8049(93)90476-v

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.

Authors:  A Berndt; H Kosmehl; U Mandel; U Gabler; X Luo; D Celeda; L Zardi; D Katenkamp
Journal:  Histochem J       Date:  1995-12

Review 2.  Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

Authors:  H Kosmehl; A Berndt; D Katenkamp
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

3.  Matrix remodelling in dilated cardiomyopathy entails the occurrence of oncofetal fibronectin molecular variants.

Authors:  U Gabler; A Berndt; H Kosmehl; U Mandel; L Zardi; S Müller; A Stelzner; D Katenkamp
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

4.  Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts.

Authors:  P Pujuguet; A Hammann; M Moutet; J L Samuel; F Martin; M Martin
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

5.  Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling?

Authors:  L David
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

6.  Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.

Authors:  T Takano; F Matsuzuka; A Miyauchi; T Yokozawa; G Liu; S Morita; K Kuma; N Amino
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.